Showing results (211-220 of 255) with videos related to

Sort By:
Pageof 26
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patientsM Charrier, L Mezquita, B Lueza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohortJ Mazières, F Barlesi, T Filleron, et al.
Diagnostic and Interventional Imaging|October 6, 2020
Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung diseaseL Tselikas, L Garzelli, O Mercier, et al.
ESMO Open|June 22, 2026
Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC)C Parisi, M Banini, F Mantuano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I databaseP A Cassier, V Polivka, I Judson, et al.
British Journal of Cancer|August 23, 2012
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albuminA Ploquin, D Olmos, D Lacombe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodiesM Collins, J M Michot, F X Danlos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancerJ-C Soria, S N Ho, M Varella-Garcia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2016
Consensus on precision medicine for metastatic cancers: a report from the MAP conferenceC Swanton, J-C Soria, A Bardelli, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2017
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumoursA Hollebecque, R Bahleda, L Faivre, et al.
Pageof 26